Brent Saunders; Chairman of the Board, Chief Executive Officer; Bausch & Lomb Corp Sam Eldessouky ... and a thoughtful approach to how we introduce multi focal and tour options in new markets ...

and Daily SiHy lenses and Bausch + Lomb ULTRA ® in our contact lens business. Surgical segment revenue was $231 million for the fourth quarter of 2024, as compared to $204 million for the fourth ...

Welcome to the Bausch + Lomb Fourth Quarter 2024 Earnings Call ... sales excellence and a thoughtful approach to how we introduce multifocal and toric options in new markets around the world.

Bausch & Lomb is one of the largest vision care companies ... With an upcoming launch of multifocal and toric lenses in the Infuse line (daily silicone hydrogels), we expect Bausch to win over ...

After completing $300 billion in healthcare deals over several decades, there is one deal Bausch and Lomb (BLCO) chairman and CEO Brent Saunders won't be making in 2025. The one for his contact ...

After completing $300 billion in healthcare deals over several decades, there is one deal Bausch and Lomb (BLCO) chairman and CEO Brent Saunders won't be making in 2025. The one for his contact lens ...

Bausch + Lomb reported solid Q4 and full-year 2024 earnings, with CEO Brent Saunders highlighting positives while avoiding the critical issue of Bausch Health's potential sale of its 88% stake.

We apologize, but this video has failed to load. VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its fourth-quarter and full-year 2024 ...

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.24 per share a year ago.

Bausch + Lomb Corp (BLCO) reported stronger-than-expected results for the fourth quarter of 2024, with both earnings per share (EPS) and revenue surpassing analyst forecasts. The company posted an ...